ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.740
+0.740 (24.67%)
At close: Jan 7, 2026
10.00%
Market Cap59.02M
Revenue (ttm)8.96M
Net Income (ttm)-4.50M
Shares Out18.33M
EPS (ttm)-0.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,762
Average Volume19,466
Open3.020
Previous Close3.000
Day's Range3.020 - 3.740
52-Week Range1.000 - 4.980
Beta0.80
RSI54.69
Earnings DateFeb 26, 2026

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2025, ODI Pharma AB's revenue was 3.13 million, a decrease of -85.94% compared to the previous year's 22.29 million. Losses were -5.93 million, 944.5% more than in 2024.

Financial Statements

News

There is no news available yet.